Followers | 838 |
Posts | 120392 |
Boards Moderated | 18 |
Alias Born | 09/05/2002 |
![](https://investorshub.advfn.com/uicon/14742.png?cb=1465058685)
Monday, March 18, 2019 4:15:27 PM
https://www.sec.gov/Archives/edgar/data/1570562/000157056219000035/q418eolsex992.htm
https://www.sec.gov/Archives/edgar/data/1570562/000157056219000035/q418eolsex991.htm
The term loan pays interest at 9.5%.
Although EOLS’ Jeuveau was approved by the FDA on 2/1/18, the product has not yet been launched.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent EOLS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2024 01:45:54 AM
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 • Business Wire • 09/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:14:51 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/09/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 09:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:12:11 PM
- Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance • Business Wire • 07/31/2024 08:05:00 PM
- Evolus to Hold Investor Day on September 12, 2024 • Business Wire • 07/31/2024 12:00:00 PM
- Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia • Business Wire • 07/30/2024 12:00:00 PM
- Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference • Business Wire • 07/25/2024 12:00:00 PM
- Evolus to Report Second Quarter Financial Results on July 31, 2024 • Business Wire • 07/17/2024 12:00:00 PM
- Evolus Announces Appointment of Albert G. White III to Board of Directors • Business Wire • 07/01/2024 12:00:00 PM
- Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products • Business Wire • 06/24/2024 12:00:00 PM
- Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain • Business Wire • 06/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:05:21 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/07/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:01:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2024 09:45:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 01:30:56 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/05/2024 09:22:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 08:25:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 09:53:10 PM
- Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting • Business Wire • 05/20/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 09:19:49 PM
- Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit • Business Wire • 05/15/2024 12:30:00 PM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM